Tag: Fda recalls

Recalls of over-the-counter medications, though infrequent, are a normal part of consumer safety and can happen for a variety of reasons. For those who rely on this popular antihistamine, the question, 'Has Claritin been recalled?' has come up periodically over the years, prompting concern among consumers. While there have been limited recalls involving specific lots of Claritin and its generic versions, these are typically not due to a widespread health risk but rather issues with manufacturing or packaging. This article provides a comprehensive overview of past Claritin and generic loratadine recalls, explaining the details and the safety measures in place to protect consumers.

Several recalls for timolol maleate ophthalmic solutions have been issued in recent years, including multiple notices in 2024 and 2025 by FDC Limited and its distributor Rising Pharmaceuticals. These recalls primarily stemmed from issues with defective product containers, highlighting the need for patients to be vigilant about medication safety.

The U.S. Food and Drug Administration (FDA) and Consumer Product Safety Commission (CPSC) regularly issue recalls to protect consumers from potentially unsafe products. This leads many to ask what cold medicine was recalled recently, particularly in late 2024 and 2025, due to issues ranging from child-resistant packaging failures to microbial contamination.

A study of drugs approved by a major regulatory body between 1990 and 2009 found that around 4.2% were eventually withdrawn for safety reasons. Understanding what of FDA drugs get pulled from the market requires insight into the rigorous post-approval monitoring that can uncover previously unknown risks or issues with manufacturing.

The persistent question, "Why was milk of magnesia taken off the market?," stems from a significant medication recall, but the premise of permanent market withdrawal is a misconception. In reality, specific batches of the laxative were subject to a voluntary nationwide recall by one manufacturer in 2022 due to concerns over microbial contamination, not a market-wide discontinuation.

In 2023, the U.S. Food and Drug Administration (FDA) saw 1,296 pharmaceutical recalls, a number that highlights the ongoing challenges in drug quality and safety. Understanding the answer to 'How many drugs does the FDA recall every year?' reveals a complex system designed to protect public health.

Since its introduction, various manufacturers of tamsulosin, including those producing generic versions, have issued recalls for the drug due to manufacturing defects and contamination concerns. The most common issues leading to these recalls include the failure of capsules to dissolve properly and the discovery of carcinogenic impurities like nitrosamines.

Several opioid medications have been pulled from the market in recent years due to safety and misuse concerns, leaving many patients and healthcare providers asking **what opioids are being discontinued**. These withdrawals often occur in response to regulatory action, adverse event reports, or a company's decision to stop producing a product, and have a significant impact on pain management protocols.